Background: Substance use disorders, including opioid use disorder (OUD), are understood
as chronic diseases with a relapsing and remitting course and no known cure. Medications …

Office-Based Opioid Treatment (OBOT) with buprenorphine has been available since 2000;
however, many barriers to OBOT within primary care exist, and only 3.6% of family medicine …

Background: Despite efforts to improve access to Medications for Opioid Use Disorder
(MOUD), such as buprenorphine, the number of opioid overdoses in the United States …

Background Prescribing medication for opioid use disorder (MOUD) in primary care helps
meet treatment demand, but few studies examine long-term treatment retention among …

Background and aims Opioid use disorder (OUD) remains a serious public health issue, and
treating adults with OUD is a major priority in the United States. Little is known about trends …

Background Efforts to increase opioid use disorder (OUD) treatment have focused on
primary care. We assessed primary care physicians' preparedness to identify and treat …

Introduction: Despite evidence demonstrating that medications for opioid use disorder
(OUD) reduce morbidity and mortality, the majority of patients do not receive treatment. The …

Purpose► primary care physicians are at the center of a national prescription opioid
epidemic, with little training or knowledge about the management of patients on opioids for …

Objectives Evidence-based therapies for opioid use disorder (OUD) and chronic pain, such
as medications for OUD (MOUD) and complementary and integrative health (CIH; eg …

Introduction: Opioid use disorder (OUD) is a major and growing public health concern, and
Medicare patients have nearly double the proportion of OUD prevalence compared with …